Christopher Friese, Ph.D., R.N., AOCN, FAAN

Dr. Christopher R. Friese is a national authority in measuring and improving the quality of cancer care delivery. Over his career, he has led pivotal studies to develop and test strategies to improve outcomes of high-risk care. His research findings were among the first to establish a significant relationship between favorable nurse practice environments and lower surgical mortality. With over 100 peer-reviewed publications, Dr. Friese's research findings have informed clinical practice guidelines, and state and federal health policy. Dr. Friese spent 2016-2017 as a Robert Wood Johnson Foundation Health Policy Fellow in the United States Senate. A clinical expert in hematological malignancies and advanced cancers, Dr. Friese continues to practice as a staff nurse at the University of Michigan Rogel Cancer Center. In 2021, the President appointed Dr. Friese to a six year term on the National Cancer Advisory Board, which sets national cancer research policy. In 2021, the President appointed Dr. Friese to a six-year term on the National Cancer Advisory Board, which sets national cancer research policy. Dr Friese serves as the Vice Provost for Academic and Faculty Affairs at the University of Michigan, with leadership of faculty matters across 13 schools and colleges.